Pulmonx Corporation

Historical 13F Holders

Symbol
LUNG
CUSIP
745848101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 745848101 since 12/18/2024, largest first.

Filer % of Class Filed
Primecap Management Co/CA/ 13G/A 12.2% 11/13/2025
Event 9/30/2025
Morgan Stanley 13G/A
6.9% 8/13/2026
Event 6/30/2026
Soleus Capital Master Fund, L.P. 13G
6.5% 3/9/2026
Event 3/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
BlackRock, Inc. 13G/A 1.8% 7/29/2026
Event 6/30/2026
FMR LLC 13G/A
0.2% 11/7/2025
Event 10/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 7 128 k $245 k
2026 Q2 111 26.2 M $34.1 M
2026 Q1 118 31.8 M $41.0 M
2025 Q4 119 32.4 M $71.6 M
2025 Q3 110 32.3 M $52.4 M
2025 Q2 116 36.8 M $95.2 M
2025 Q1 122 36.3 M $244 M
2024 Q4 127 36.0 M $244 M
2024 Q3 121 36.6 M $302 M
2024 Q2 117 39.3 M $249 M
2024 Q1 125 40.2 M $373 M
2023 Q4 131 36.5 M $465 M
2023 Q3 123 33.3 M $344 M
2023 Q2 119 33.9 M $444 M
2023 Q1 113 34.7 M $388 M
2022 Q4 125 34.4 M $290 M
2022 Q3 109 34.9 M $582 M
2022 Q2 109 35.3 M $520 M
2022 Q1 118 34.7 M $861 M
2021 Q4 126 32.8 M $1.05 B
2021 Q3 126 31.6 M $1.14 B
2021 Q2 118 25.9 M $1.14 B
2021 Q1 114 21.6 M $988 M
2020 Q4 103 18.5 M $1.26 B